{"disease":{"id":"lower-grade-glioma-recurrent","name":"lower grade glioma recurrent"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04267978","title":"Study of Recombinant Human Endostatin Combined with Temozolomide and Irinotecan in Recurrent Gliomas","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":109,"lead_sponsor_name":"Beijing Sanbo Brain Hospital","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}